Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Fosun International ( (HK:0656) ) has shared an update.
Fosun International has warned that its loss attributable to shareholders for 2025 is expected to widen sharply to about RMB21.5 billion to RMB23.5 billion, compared with a loss of roughly RMB4.35 billion in 2024. The company cites substantial one-off, non-cash impairment charges and asset revaluations, particularly in its struggling real estate segment and certain non-core businesses, as the main driver of the larger book loss.
The board stressed that these impairments are prudential measures intended to present a faithful picture of asset values and do not impact the group’s overall operations or cash flow. It highlighted stable fundamentals and positive trends in core pharmaceutical, healthcare, insurance and finance businesses, reaffirming its focus on core operations, tighter financial discipline and refined management to support long-term value and shareholder returns.
The most recent analyst rating on (HK:0656) stock is a Hold with a HK$4.00 price target. To see the full list of analyst forecasts on Fosun International stock, see the HK:0656 Stock Forecast page.
More about Fosun International
Fosun International is a Hong Kong-listed conglomerate with core operations in pharmaceuticals and healthcare, as well as insurance and finance. The group also has significant exposure to real estate and various non-core businesses, and is pursuing a strategy of focusing on principal businesses while streamlining operations and strengthening its financial position.
Average Trading Volume: 18,028,628
Technical Sentiment Signal: Sell
Current Market Cap: HK$29.57B
Learn more about 0656 stock on TipRanks’ Stock Analysis page.